Physician profile
Gitty Orzechowitz
NPI 1144624107
$333.60
in general payments reported to CMS, 2019-2025
7 companies · $66.54 in 2025
The $66.54 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $145 · 2025: $66.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $89.93 | 2024-2025 | |
| Phadia US INC. | $64.03 | 2023-2024 | Immunocap |
| Sanofi Pasteur INC. | $51.65 | 2023-2024 | |
| Glaxosmithkline, LLC. | $47.29 | 2023-2024 | Bexsero, Pediarix, Rotarix |
| Verrica Pharmaceuticals INC. | $29.95 | 2024 | Ycanth |
| Kaleo, INC. | $25.55 | 2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $25.20 | 2023 | Gardasil 9, Vaxneuvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gitty Orzechowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.